Trimi vs Remedy Meds

Both sell tirzepatide. Trimi costs $125 a month and Remedy Meds costs $399, a difference of $274 a month or about $3,288 a year. The desk reads it as follows.

Trimi is lowest flat price with named pharmacies. Remedy Meds is flat pricing with unlimited clinician access. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Advert against bill. Trimi advertises $125 and bills $125; Remedy Meds advertises $279 and bills $399. The gaps are different sizes, which means comparing the two on their advertised prices gives you the wrong answer.

Side by side

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The split

They differ on 3 of the 7 things we track, and behave the same on the other 4. The differences are what the price gap is actually buying.

What each puts on the record: Trimi

• Compounded tirzepatide advertised at $125/month on the annual plan.
• Compounded semaglutide advertised at $99/month on the annual plan.
• Price is the same at every prescribed dose.
• One flat charge covers medication, clinician visits, check-ins and free overnight shipping; no separate membership.
• Names its compounding pharmacies publicly: VialsRx (Texas Board of Pharmacy #35264) and GreenwichRx, with a certificate of analysis available on request.
• Medical oversight via Arora Health, a 50-state network led by Dr. Sean Arora, MD.
• Advertises a six-month money-back promise subject to terms.

Where it wins: The cheapest verified flat rate for compounded tirzepatide in this comparison. Watch for: Both headline prices are annual-plan rates. Confirm the month-to-month figure and the refund terms before prepaying twelve months.

What each puts on the record: Remedy Meds

• Compounded semaglutide priced at $299/month flat, regardless of dose.
• Compounded tirzepatide priced at $399/month flat, regardless of dose.
• First month of tirzepatide discounted to $279, then $399/month.
• Medication is included in the monthly fee rather than billed separately.
• Unlimited clinician access, check-ins and dose adjustments included.
• Branded Zepbound offered at around $1,399/month.

Where it wins: Genuinely flat pricing — the dose can go to the top of the ladder without the bill moving. Watch for: The $279 introductory tirzepatide month renews at $399. Budget from the renewal figure.

In each one’s favour

Trimi.

• The cheapest verified flat rate for compounded tirzepatide in this comparison.
• Names its pharmacies with a licence number and offers a certificate of analysis — almost nobody else in this market does.

Remedy Meds.

• Genuinely flat pricing — the dose can go to the top of the ladder without the bill moving.
• Unlimited clinician access is included rather than sold as an upgrade.

How they score

Trimi scores higher overall at 4.6 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

The desk’s call

• Pick Trimi if cost is the binding constraint. Over a year the gap is about $3,288, which is real money for the same class of medication.
• Pick Remedy Meds if what it does better matters to you — genuinely flat pricing — the dose can go to the top of the ladder without the bill moving.
• If sourcing matters, note that Trimi publishes which pharmacy compounds its medication and Remedy Meds does not.

The verdict

On the board, Trimi at $125 a month is the more defensible choice on arithmetic alone. Remedy Meds earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Trimi and Remedy Meds.

How they sit against everyone else